RPRX Market Cap & Key Metrics
Royalty Pharma plc
$67.30
-$0.27(-0.40%)
84
Overall
100
Value
100
Tech
52
Quality
Market Cap
$38.60B
Volume
4.84M
52W Range
$37.31 - $69.77
Target Price
$71.57
RPRX market cap is $38.60B. This page lists Royalty Pharma plc's P/E ratio, EPS estimates, dividend yield, payout ratio and MarketXLS scores.
RPRX Key Metrics
- Market cap
- $38.60B
- P/E ratio (current-year EPS estimate)
- 12.60
- EPS estimate, current year
- $5.34
- Dividend yield (TTM)
- 1.37%
- Payout ratio
- 60.5%
- EPS growth, 3-year
- +161.59%
- Value score
- 100
- Quality score
- 52
- Technical score
- 100
| Fiscal year | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Revenue | $2.38B | $2.26B | $2.35B | $2.24B | $2.29B |
| EBITDA | $1.64B | $1.56B | $1.89B | $418.02M | $1.43B |
| EPS | $1.79 | $1.92 | $2.54 | $0.10 | $1.49 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | RPRX | $67.30 | -0.4% | 4.84M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |